Study Evaluating Mitoxantrone in Multiple Sclerosis

NCT00146159 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

336

Enrollment

INDUSTRY

Sponsor class

Conditions

Secondary Progressive Multiple Sclerosis

Interventions

DRUG: Mitoxantrone

Sponsor

Wyeth is now a wholly owned subsidiary of Pfizer